Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Lung Cancer. 2016 Aug 16;100:102–109. doi: 10.1016/j.lungcan.2016.08.008

Table 4.

Association between Instrument Scores and Mortality

HR* (CI 95%) p value Adj HR*# (CI 95%) p value p value Interaction*# (depression symptoms x instrument)
Instrument
SF-12
 PCS 0.80 (0.75–0.85) <0.001 0.87 (0.82–0.93) <0.001 0.94
 MCS 0.90 (0.85–0.95) <0.001 0.94 (0.89–1.01) 0.078 0.66
EQ-5D 0.84 (0.80–0.89) <0.001 0.89 (0.84–0.95) <0.001 0.59
SF-36 (Vitality) 0.83 (0.79–0.88) <0.001 0.91 (0.85–0.96) 0.002 0.25
EORTC QLQ-30^ 1.18 (1.12–1.25) <0.001 1.09 (1.03–1.16) 0.004 1.00
EORTC QLQ-LC13 1.24 (1.18–1.31) <0.001 1.14 (1.08–1.21) <0.001 0.008
Powe Fatalism Inventory^ 0.95 (0.90–1.01) 0.11 0.96 (0.90–1.03) 0.25 0.38
MOS Social Support Survey^
 Emotional/Informational 0.96 (0.91–1.02) 0.21 1.01 (0.95–1.07) 0.71 0.04
 Tangible/instrumental 0.96 (0.91–1.01) 0.12 0.98 (0.93–1.04) 0.53 0.26
*

Scores standardized to unit of one standard deviation for comparison;

#

Adjusted by age, race, sex, income, education, smoking history, marital status, comorbidities and cancer stage and histology;

^

Selected items

Abbreviations: SF-12= Medical Outcomes Study 12-item short form, EQ-5D=EuroQol questionnaire, SF-36 Medical Outcomes Study 36-item short form vitality scale, EORTC QLQ-30= European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, LC-13=Lung Cancer Modular Questionnaire, and MOS=Medical Outcomes Study.